EZA- Eza alcohol free named product of the year in its category
Hellenic Breweries of Atalanti earned the “Voted Product of the Year” award for eza Alcohol Free beer from the Greek Voted Product of the Year organisation that works to promote innovation in consumer products and services on the Greek market. The “alcohol-free beer as it should be” was selected through consumer voting conducted by the IRI Greece market research company.
Diorama concluded its tenth investment in Hellenic Breweries of Atalanti
DECA Investments AIFM, the exclusive investment manager of Diorama Investments SICAR (“Diorama” or the “Fund”), announced the completion of the Fund’s tenth investment: the acquisition of a strategic minority position in Hellenic Breweries of Atalanti (“EZA” or the “Company”). The funds will be used mainly for the further development of the company through the financing of its working capital and capital investment needs resulting from the execution of its four-year business plan.
Regarding Viva
In December 2019, Viva successfully concluded a Series C round financing of EUR 75mn at a valuation 3x of the Series B round.
Pharos – Participation in CPhI 2019
Pharos participated in the CPhI Worldwide exhibition, which this year took place in Frankfurt. CPhI has hosted more than 48,000 visiting pharma professionals over three days. 2,500+ exhibitors from 170+ countries gather at the event to network and take advantage of more than 100+ free industry seminars.
Diorama concluded its investment in PharOs
DECA Investments AIFM, the exclusive investment manager of Diorama Investments SICAR (“Diorama” or the “Fund”), announced the completion of the Fund’s ninth investment: the acquisition of a 25% stake in PharOs (“PharOs” or the “Company”).
Minerva S.A. acquisition completed
ELAIA ZEUS S.A., a company controlled by the Investment Fund Diorama Investments Sicar S.A. in which also participates the investment Fund Elikonos 2 SCA Sicar, announces that it completed today the acquisition of the company MINERVA S.A. John Kalantzis, the Chief Investment Officer of DECA Investments AIFM stated: “I would like to thank all those who worked hard during these last months for the completion of this acquisition. We will work together with Minerva’s excellent human capital in order to further improve the growth potential οf the company”.
GMP Certification for Pharos MT
Pharos received the GMP certification for the production facility of Pharos Malta (Pharos MT). Pharos MT’s facility is located in Hal Far manufacturing site and has the capacity to produce 1.5 billion tablets per annum. Pharos acquired the facility in May 2018 from Teva in an effort to transition from a purely development to a development & manufacturing organisation.
Atlas Tapes completed the installation of the new pressure sensitive adhesive tapes production line, with the use of the solvent-based technology
Atlas Tapes completed the installation of the new pressure sensitive adhesive tapes production line, with the use of the solvent-based technology
LARIPLAST
“…You need to do a conversion in your way of thinking in order to begin to love waste as a material.” Taeke de Jong (Ed van Hinte, 2007, 78). The increased acceptance of plastics by consumers and industry is due to their clear advantages over other materials. Their low weight and low material requirements are by far their most important asset.
Diorama concluded its seventh investment in Lariplast
DECA Investments AIFM, the exclusive investment manager of Diorama Investments SICAR (“Diorama” or the “Fund”), announced the completion of the Fund’s seventh investment: the acquisition of a strategic minority equity position in Lariplast S.A. (“Lariplast” or the “Company”) for a consideration of five million four hundred thousand euros.